Summary
A method is described for measuring rapid, specific, and saturable binding of the skin irritant and tumour-promoting secretagogue thapsigargin (sesquiterpene lactone) to the microsomal fraction from mouse brain. Employing the tritium-labelled compound its apparent dissociation constant,K d, and the maximal amount of bindingB max are shown to be 9.8 nM and 1.9 pmol/mg protein respectively. Such aK d for thapsigargin is similar to (a) its IC50 value for inhibiting Ca2+ uptake in the microsomal fraction from rat brain and (b) its EC50 values for inducing a rise in the cytoplasmic Ca2+ concentration of human platelets and histamine release from rat peritoneal mast cells. A positive correlation is found between the binding affinities of thapsigargin, thapsitranstagin, and trilobolide, their potencies as secretagogues and their lipophilicities. This correlation does not extend to the skin-irritant activities of the compounds thus emphasizing that their mechanism of action is unlike that of 12-O-tetradecanoylphorbol 13-acetate.
Similar content being viewed by others
Abbreviations
- Tg:
-
thapsigargin
- Tt:
-
thapsitranstagin
- Tr:
-
trilobolide
- TPA:
-
12-O-tetradecanoylphorbol 13-acetate
- K i,K d :
-
apparent inhibition and dissociation constants
- ID 550 :
-
irritant dose for 50% response after 5 h
References
Ali H, Christensen SB, Foreman JC, Pearce FL, Piotrowski W, Thastrup O (1985) The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br J Pharmacol 85:705–712
Ashendel CL, Boutwell RK (1981) Direct measurement of specific binding of highly lipophilic phorbol diester to mouse epidermal membranes using cold acetone. Biochem Bophys Res Commun 99:543–549
Bennett JP (1978) Methods in binding studies in neurotransmitter receptor binding. In: Yamamura HI, Enna SJ, Kuhar MJ (eds) Neurotransmitter receptor binding. Raven Press, New York, pp 57–90
Christensen SB (1985) Radiolabelling of the histamine liberating sesquiterpene lactone, thapsigargin. J Labelled Compd Radiopharm 22:71–77
Christensen SB, Andersen A, Lauridsen A, Moldt P, Smitt U, Thastrup O (1992) Thapsigargin a lead to design of drugs with the calcium pump as target. In: Krogsgaard-Larsen P, Christensen SB, Kofod H (eds) New lead and targets in drug design. Munksgaard, Copenhagen (in press)
Delclos KB, Nagle DS, Blumberg PM (1980) Specific binding of phorbol ester tumour promoters to mouse skin. Cell 19:1025–1032
Dunphy WG, Delclos KB, Blumberg PM (1980) Characterization of specific binding of [3H]-phorbol 12,13-dibutyrate and [3H]-phorbol 12-myristate 13-acetate to mouse brain. Cancer Res 40:3635–3641
Gouy H, Cefai D, Christensen SB, Debré P, Bismuth G (1990) Ca2+ influx in humar T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. Eur J Immunol 20:2269–2275
Hakii H, Fujiki H, Suganuma M, Nakayasu M, Tahira T, Sugimura T, Scheuer PJ, Christensen SB (1986) Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumour promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol 111:177–181
Hecker E (1985) Cell membrane associated protein kinase C as a receptor of diterpene ester cocarcinogens of the promoter type and the phenotypic expression of tumours. Drug Res II, Special issue 12a:1890–1903
Hecker E, Immich H, Bresch H, Schairer HU (1966) Über die Wirkstoffe des Crotonöls. Z Krebsforsch 68:366–374
Hergenhahn M, Hecker E (1981) Specific binding of the tumour promoter TPA in various mouse organs as measured by a “cold acetone-filter assay”. Carcinogenesis 2:1277–1281
Hergenhahn M, Kloz U, Fellhauer M, Tremp GI, Hecker E (1991) Toxicodynamics of tumour promoters of mouse skin: II. Binding to protein kinase C of some new diterpene esters and induction of luminol-enhanced chemiluminescence in mouse peritoneal neutrophils. J Cancer Res Clin Oncol 117:385–395
Jackson TR, Patterson SI, Thastrup O, Hanley MR (1988) A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells. Biochem J 253:81–86
Kano S, Iizuka T, Ishimura Y, Fujiki H, Sugimura T (1987) Stimulation of superoxide anion formation by the non-TPA type tumour promoters palytoxin and thapsigargin in porcine and human neutrophils. Biochem Biophys Res Commun 143:672–677
Mikkelsen EO, Thastrup O, Christensen SB (1988) Effects of thapsigargin in isolated rat thoracic aorta. Pharmacol Toxicol 62:7–11
Norup E, Smitt UW, Christensen SB (1986) The potencies of thapsigargin and analogues as activators of rat peritoneal mast cells. Planta Med 251–255
Ohuchi K, Sugawara T, Watanabe M, Hirasawa N, Tsurufuji S, Fujiki H, Sugimura T, Christensen SB (1987) Stimulation of arachidonic acid metabolism in rat peritoneal macrophages by thapsigargin, a non-(12-O-tetradecanoylphorbol-13-acetate) (TPA)-type tumour promoter. J Cancer Res Clin Oncol 113:319–324
Schmidt R, Fujiki H, Hecker E, Sugimura T (1981) Is the in vitro binding of phorbol esters to fractions of mouse skin a relevant probe for studies of in vivo promotion? (abstract). J Cancer Res Clin Oncol 99:CH37
Schmidt R, Adolf W, Marston A, Roeser H, Sorg B, Fujiki H, Sugimura T, Moore RE, Hecker E (1983) Inhibition of specific binding of [3H]-phorbol 12,13-dipropionate to an epidermal fraction by certain irritants and irritant promoters of mouse skin. Carcinogenesis 4:77–81
Supattapone S, Danoff SK, Theibert A, Joseph SK, Steiner J, Snyder SH (1988) Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc Natl Acad Sci USA 85:8747–50
Taylor CW (1990) Receptor-regulated Ca2+ entry: secret pathway or secret messenger? Trends Pharmacol Sci 11:269–271
Thastrup O, Cullen PJ, Drøbak BK, Hanley MR, Dawson AP (1990) Thapsigargin, a tumour promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci USA 87:2466–2470
Verma A, Hirsch DJ, Hanley MR, Thastrup O, Christensen SB, Snyder SH (1990) Inositol trisphosphate and thapsigargin discriminate endoplasmic reticulum stores of calcium in rat brain. Biochem Biophys Res Commun 172:811
Author information
Authors and Affiliations
Additional information
For II see Hergenhahn et al. 1991
Rights and permissions
About this article
Cite this article
Christensen, S.B., Hergenhahn, M., Roeser, H. et al. Toxicodynamics of tumour promoters of mouse skin III. Specific binding of the tumour promoter thapsigargin as measured by the cold-acetone filter assay. J Cancer Res Clin Oncol 118, 344–348 (1992). https://doi.org/10.1007/BF01294438
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01294438